198 related articles for article (PubMed ID: 31307653)
21. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
[TBL] [Abstract][Full Text] [Related]
22. Differentiating brain metastasis from glioblastoma by time-dependent diffusion MRI.
Kamimura K; Kamimura Y; Nakano T; Hasegawa T; Nakajo M; Yamada C; Akune K; Ejima F; Ayukawa T; Ito S; Nagano H; Takumi K; Nakajo M; Uchida H; Tabata K; Iwanaga T; Imai H; Feiweier T; Yoshiura T
Cancer Imaging; 2023 Aug; 23(1):75. PubMed ID: 37553578
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of the apparent diffusion coefficient for the evaluation of the white matter to differentiate between glioblastoma and brain metastases.
Miquelini LA; Pérez Akly MS; Funes JA; Besada CH
Radiologia; 2016; 58(3):207-13. PubMed ID: 26655126
[TBL] [Abstract][Full Text] [Related]
24. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.
Kickingereder P; Wiestler B; Sahm F; Heiland S; Roethke M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
Radiology; 2014 Sep; 272(3):843-50. PubMed ID: 24814181
[TBL] [Abstract][Full Text] [Related]
25. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
[TBL] [Abstract][Full Text] [Related]
26. Diffusion-weighted magnetic resonance imaging for detection of postoperative intracranial pyogenic abscesses in neurosurgery.
Schwartz C; Lenski M; Romagna A; Schichor C; Tonn JC; Brueckmann H; Janssen H; Liebig T; Forbrig R; Thon N
Acta Neurochir (Wien); 2019 May; 161(5):985-993. PubMed ID: 30915573
[TBL] [Abstract][Full Text] [Related]
27. Cerebral abscesses and necrotic cerebral tumours: differential diagnosis by perfusion-weighted magnetic resonance imaging.
Muccio CF; Esposito G; Bartolini A; Cerase A
Radiol Med; 2008 Aug; 113(5):747-57. PubMed ID: 18414811
[TBL] [Abstract][Full Text] [Related]
28. Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.
Kim JY; Park JE; Jo Y; Shim WH; Nam SJ; Kim JH; Yoo RE; Choi SH; Kim HS
Neuro Oncol; 2019 Feb; 21(3):404-414. PubMed ID: 30107606
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of apparent diffusion coefficient in differentiating between high-grade gliomas and brain metastases.
Caravan I; Ciortea CA; Contis A; Lebovici A
Acta Radiol; 2018 May; 59(5):599-605. PubMed ID: 28835111
[TBL] [Abstract][Full Text] [Related]
30. Accuracy of apparent diffusion coefficient in differentiation of glioblastoma from metastasis.
Beig Zali S; Alinezhad F; Ranjkesh M; Daghighi MH; Poureisa M
Neuroradiol J; 2021 Jun; 34(3):205-212. PubMed ID: 33417503
[TBL] [Abstract][Full Text] [Related]
31. Diffusion-weighted MR imaging in the preoperative assessment of brain abscesses.
Leuthardt EC; Wippold FJ; Oswood MC; Rich KM
Surg Neurol; 2002 Dec; 58(6):395-402; discussion 402. PubMed ID: 12517619
[TBL] [Abstract][Full Text] [Related]
32. Brain Abscess Apparent Diffusion Coefficient is Associated With Microbial Culture Yields.
Toh CH; Siow TY; Wong AM; Castillo M
J Magn Reson Imaging; 2021 Aug; 54(2):598-606. PubMed ID: 33599050
[TBL] [Abstract][Full Text] [Related]
33. Differentiation between primary CNS lymphoma and atypical glioblastoma according to major genomic alterations using diffusion and susceptibility-weighted MR imaging.
Ozturk K; Soylu E; Cayci Z
Eur J Radiol; 2021 Aug; 141():109784. PubMed ID: 34051685
[TBL] [Abstract][Full Text] [Related]
34. Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging.
Wang S; Kim S; Chawla S; Wolf RL; Zhang WG; O'Rourke DM; Judy KD; Melhem ER; Poptani H
Neuroimage; 2009 Feb; 44(3):653-60. PubMed ID: 18951985
[TBL] [Abstract][Full Text] [Related]
35. Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging.
Ko CC; Tai MH; Li CF; Chen TY; Chen JH; Shu G; Kuo YT; Lee YC
PLoS One; 2016; 11(9):e0162565. PubMed ID: 27631626
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of Recurrent Glioblastoma from Delayed Radiation Necrosis by Using Voxel-based Multiparametric Analysis of MR Imaging Data.
Yoon RG; Kim HS; Koh MJ; Shim WH; Jung SC; Kim SJ; Kim JH
Radiology; 2017 Oct; 285(1):206-213. PubMed ID: 28535120
[TBL] [Abstract][Full Text] [Related]
37. The value of asphericity derived from T1-weighted MR in differentiating intraparenchymal ring-enhancing lesions-comparison of glioblastomas and brain abscesses.
Zeng T; Xu Z; Yan J
Neurol Sci; 2021 Dec; 42(12):5171-5175. PubMed ID: 33796946
[TBL] [Abstract][Full Text] [Related]
38. Gradient of apparent diffusion coefficient values in peritumoral edema helps in differentiation of glioblastoma from solitary metastatic lesions.
Lemercier P; Paz Maya S; Patrie JT; Flors L; Leiva-Salinas C
AJR Am J Roentgenol; 2014 Jul; 203(1):163-9. PubMed ID: 24951211
[TBL] [Abstract][Full Text] [Related]
39. Accuracy of apparent diffusion coefficients and enhancement ratios on magnetic resonance imaging in differentiating primary cerebral lymphomas from glioblastoma.
Anwar SSM; Baig MZ; Laghari AA; Mubarak F; Shamim MS; Jilani UA; Khalid MU
Neuroradiol J; 2019 Oct; 32(5):328-334. PubMed ID: 31188064
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of pyogenic and fungal brain abscesses with susceptibility-weighted MR sequences.
Antulov R; Dolic K; Fruehwald-Pallamar J; Miletic D; Thurnher MM
Neuroradiology; 2014 Nov; 56(11):937-45. PubMed ID: 25085012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
